Novartis to pay Matchpoint up to $1 billion to develop anti-inflammatory therapies
(Reuters) -Swiss drugmaker Novartis will pay up to $1 billion to U.S. biotech Matchpoint Therapeutic...
24th July, 2025
(Reuters) -Swiss drugmaker Novartis will pay up to $1 billion to U.S. biotech Matchpoint Therapeutic...
24th July, 2025
By Supantha Mukherjee STOCKHOLM (Reuters) -The NATO Innovation Fund has made its first investment in...
30th June, 2025
By Ludwig Burger (Reuters) -German biotech firm BioNTech has agreed to acquire domestic peer CureVac...
12th June, 2025
(Reuters) -Merck has held talks to buy Swiss biotech MoonLake Immunotherapeutics for more than $3 bi...
2nd June, 2025
(Reuters) -Sanofi said on Thursday that it would acquire Vigil Neuroscience, a clinical-stage biotec...
22nd May, 2025

ZURICH (Reuters) - Swiss biotech BioVersys, which develops treatments for serious infections caused...
6th February, 2025

STOCKHOLM (Reuters) – Danish biotech Bavarian Nordic said on Friday the order book for delivery of i...
16th November, 2024

By Patrick Wingrove (Reuters) -Novavax cut its annual revenue forecast on Tuesday, citing lower-than...
12th November, 2024

Finding the next big impact investing opportunity in the UK biotech sector By Alexandra Martinez, Co...
15th May, 2023

By Natalie Grover LONDON (Reuters) – Britain’s budget has offered a shot in the arm to research-inte...
16th March, 2023

(Reuters) – Danish biotech firm Bavarian Nordic said on Thursday it has signed up a U.S.-based manuf...
19th August, 2022

By Amruta Khandekar and Leroy Leo (Reuters) – Plunging valuations have made biotech companies tempti...
12th August, 2022